Antiviral Activity of Genital Tract Secretions following Oral or Topical Tenofovir Pre-exposure Prophylaxis for HIV-1

BACKGROUND: Surrogate markers of HIV-1 pre-exposure prophylaxis (PrEP) and microbicide efficacy are needed. One potential surrogate is the antiviral activity in cervicovaginal lavage (CVL) after exposure to candidate products. We measured CVL antiviral activity in women using oral or vaginal tenofov...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Herold, Betsy C., Dezzutti, Charlene S., Richardson, Barbra A., Marrazzo, Jeanne, Mesquita, Pedro M.M., Carpenter, Colleen, Huber, Ashley, Louissaint, Nicolette, Marzinke, Mark A., Hillier, Sharon L., Hendrix, Craig W.
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981887/
https://ncbi.nlm.nih.gov/pubmed/24457633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000110
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars